emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Phytopharm / Ixico

No EMAT : 83396
Announced Date : 23/09/2013
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Phytopharm

Target : Ixico
Country : United Kingdom
Sector of activity :
  • Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Equipment
  • Specialized Software > Business Software > Software > Medical Software
  • Specialized Software > Business Software > Software > Computer Graphics Software
Business Description :
Founded in 2004 by by Professors Derek Hill, Jo Hajnal, David Hawkes and Daniel Rueckert - from the Centre for Medical Image Computing at UCL - IXI CO is a developer of software for automating...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic ns
Current ns ns
Rating : *
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Medical Equipment » = 221
  • Number of EMAT Reports / sub-sector « Medical Software » = 75
  • Number of EMAT Reports / sub-sector « Computer Graphics Software » = 30
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
06/03/2017 Private Group Led by CVC Capital Partners Vitalia Home Spain * 83268
18/09/2015 Dechra Pharmaceuticals Genera Croatia *** 83260

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report